Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Advocacy"

Advocating for Arthritis: My First Time on the Hill

Colin C. Edgerton, MD  |  July 1, 2010

Amidst the most momentous week of the year’s tumultuous healthcare reform activities, we arrived in Washington, D.C., for the annual ACR Advocates for Arthritis Capitol Hill Fly-In. This was to be my first visit to Congress. Although my alma mater, Georgetown University, was a short distance from the Capitol dome, as a student I had little interest in the political process—particularly as it related to medicine. Now, however, as a young rheumatologist, I am increasingly aware of the impact health policy has on my daily practice. I have also watched the healthcare reform debate unfold over the last year, recognizing that this is a critical time for physicians to be vocal and active. There is a great deal at stake, and we are surrounded daily by the very issues debated in Washington. Why not take our opinions directly to the decision makers?

The Workforce Today & Tomorrow

Stanley B. Cohen, MD  |  July 1, 2010

The ACR is increasing the ranks of rheumatology on many fronts

In Advocacy, Slow and Steady Wins the Race

From the College  |  April 1, 2010

Earlier in the year, it seemed that healthcare reform was stopped in its tracks because of the Massachusetts Senate special election—which placed Republican Scott Brown in the seat held by the “Liberal Lion,” Edward M. Kennedy. The Senate Democrats lost their supermajority and the momentum to pass President Obama’s healthcare reform legislation subsided. But through strong lobbying by the president, Speaker Nancy Pelosi (D-Calif.), and Senate Majority Leader Harry Reid (D-Nev.), Congress passed the Patient Protection and Affordable Care Act (H.R. 3590)—comprehensive healthcare reform—on March 21, and the president signed the bill into law on March 23.

Call Your Lawmakers the Week of March 15

From the College  |  March 1, 2010

The elimination of consultation code services, the repeated battle to avert Medicare cuts, the need for increased research funding, the creation of a loan repayment program for pediatric rheumatologists, and fair costs for drug therapies are all issues that members of Congress have influence over. All of these issues affect the rheumatology profession, whether you are a clinical practitioner, researcher, academic, or health professional.

Thinkers Wanted: Join the Grassroots Rheumatology Think Tank

David S. Pisetsky, MD, PhD  |  March 1, 2010

We need you to join the grassroots rheumatology think tank

Don’t Just Watch Health Policy Unfold—Take Action

From the College  |  February 1, 2010

If you are tired of just watching and reading about health policy decisions that affect you, your patients, and your profession, take action today to help shape the future of healthcare. The ACR offers multiple ways for you to stay informed about legislation affecting rheumatology professionals and can teach you how to influence the decisions made on Capitol Hill.

Reach Out To Local Media to Promote Rheumatology

From the College  |  January 1, 2010

The ACR is committed to advocating on behalf of its members. This could be on Capitol Hill, by working with insurance providers, or by working with the media to promote the work of rheumatologists and rheumatology health professionals and advance the issues affecting them.

Philadelphia Displays Many Facets of the Healthcare Debate

David S. Pisetsky, MD, PhD  |  January 1, 2010

City of Brotherly Love displays many facets of the healthcare debate

Advocating for Your Interests in the Health Insurance Marketplace

Staff  |  October 1, 2009

As healthcare reform ramps up and fists grip tighter around the almighty healthcare dollar, the ACR is moving ahead full force in advocating for your interests in the delivery of healthcare. Through what could be described as “offensive” and “defensive” strategies, the ACR is positioning itself as a visible and active player in the managed care marketplace.

Obama and Clinton at the AMA

Raymond Scalettar, MD, DSc  |  September 1, 2009

Then and now: Déjà vu all over again—toujours?

  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 30
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences